hrp0089p2-p330 | Pituitary, Neuroendocrinology and Puberty P2 | ESPE2018
Phatarakijnirund Voraluck
, Numbenjapon Nawaporn
, Kooanantkul Chula
, Thanakitcharu Kwanjai
, Chaiyakul Phairuch
, Phowang Karusart
Background: Gonadotropin-releasing hormone analogs (GnRHa) are the standard treatment of central precocious puberty (CPP). Many studies demonstrate the effects of GnRHa on preserved final adult height. However, data compares the efficacy of different GnRHa on growth outcome and gonadotropin suppression in girl with CPP was limitObjective: Evaluate the effect of 2 different GnRHa on final adult height (FAH) and gonadotropin suppression in girl with CPP</p...